From 2013 to 2023, antiinfective medicine sales in South Korea declined steadily from 12.4 units to 6.8 units. The year-on-year variation saw reductions, showing a significant fall, especially from 2017 onwards. The compound annual growth rate (CAGR) over the last 5 years reached -8.32%, indicating an average annual decrease in the market size of 8.32%. Forecasts predict that sales will further decline, reaching 3 units by 2028, with a forecasted 5-year CAGR of -12.94% and a forecasted 5-year growth rate of -50%.

Future trends to watch for:

Continued reduction in antiinfective medicine usage due to improved healthcare practices and preventive measures.
Potential shifts in market dynamics as new healthcare policies are implemented.
Evolving landscape with technological advancements in the pharmaceutical industry impacting traditional antiinfective treatments.